| CpG oligonucleotides as vaccine adjuvants N Kayraklioglu, B Horuluoglu, DM Klinman DNA Vaccines: Methods and Protocols, 51-85, 2021 | 67 | 2021 |
| Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99 H Çelik, M Sciandra, B Flashner, E Gelmez, N Kayraklıoğlu, ... Oncogene 37 (16), 2181-2196, 2018 | 30 | 2018 |
| PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus B Horuluoglu, D Bayik, N Kayraklioglu, E Goguet, MJ Kaplan, DM Klinman Journal of autoimmunity 99, 24-32, 2019 | 28 | 2019 |
| PAM3 protects against DSS-induced colitis by altering the M2: M1 ratio BH Horuluoglu, N Kayraklioglu, D Tross, D Klinman Scientific Reports 10 (1), 6078, 2020 | 22 | 2020 |
| Effect of calcium carbonate encapsulation on the activity of orally administered CpG oligonucleotides N Kayraklioglu, J Scheiermann, WG Alvord, DM Klinman Molecular Therapy-Nucleic Acids 8, 243-249, 2017 | 9 | 2017 |
| Perceptions of controversies and unresolved issues in the 2014 FIGO staging system for endometrial cancer: survey results from members of the International Society of … N Kayraklioglu, L Katsakhyan, PA Cohen, N Singh, JT Rabban, ... International Journal of Gynecological Pathology 43 (3), 242-252, 2024 | 3 | 2024 |
| Critical role of B cells in Toll-like receptor 7-mediated protection against Listeria monocytogenes infection N Kayraklioglu, B Horuluoglu, M Elango, DM Klinman Infection and Immunity 87 (12), 10.1128/iai. 00742-19, 2019 | 1 | 2019 |
| Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus–Positive Carcinomas of the Urinary Tract N Kayraklioglu, BA Stohr, E Chan Archives of Pathology & Laboratory Medicine, 2024 | | 2024 |
| Intact Chorionic Vesicle in Very Early Products of Conception Specimens: Clinicopathologic Features of 26 Cases That May Mimic Complete Hydatidiform Mole N Kayraklioglu, C Gasper, SJ Cho, J Lage, JT Rabban The American Journal of Surgical Pathology 47 (3), 397-408, 2023 | | 2023 |
| Comprehensive Molecular Characterization of Recurrent Low Grade/Low Stage Endometrial Endometrioid Carcinomas N Kayraklioglu, W Devine, N Ladwig, K Garg, J Chapman, J Rabban LABORATORY INVESTIGATION 102 (SUPPL 1), 772-774, 2022 | | 2022 |
| Molecular Characterization of High-Risk Human Papilloma Virus-Positive Carcinomas of the Urethra and Urothelial Tract N Kayraklioglu, W Devine, B Stohr, E Chan LABORATORY INVESTIGATION 102 (SUPPL 1), 611-612, 2022 | | 2022 |
| Association of Kikuchi Fujimoto-Like Lymphadenitis and Malignancy: A Retrospective Clinicopathologic Analysis N Kayraklioglu, R Ohgami, R Balassanian, R Ruiz-Cordero LABORATORY INVESTIGATION 101 (SUPPL 1), 864-865, 2021 | | 2021 |
| Chorionic Vesicle in Early Trimester Products of Conception: A Rare Mimic of Early Complete Hydatidiform Mole N Kayraklioglu, SJ Cho, J Lage, J Rabban LABORATORY INVESTIGATION 101 (SUPPL 1), 703-704, 2021 | | 2021 |
| A Morphologic Analysis of Hemophagocytosis in Liver Biopsies Identifies an Association Between Multicellular Erythrophagocytosis, Aggressive NK or T-Cell Lymphomas, and … A Kikuchi, E Gars, N Kayraklioglu, R Ruiz-Cordero, R Gill, KW Wen, ... LABORATORY INVESTIGATION 101 (SUPPL 1), 971-972, 2021 | | 2021 |
| Oral R848 Reduces Host Susceptibility to Enteric and Systemic L. monocytogenes Challenge N Kayraklioglu, BH Horuluoglu, M Elango, A Turan, DM Klinman The Journal of Immunology 202 (1_Supplement), 196.4-196.4, 2019 | | 2019 |
| Modulation of TLR2/1 by PAM3CSK4 to induce generation of immunosuppressive macrophages as a therapeutic approach for SLE BH Horuluoglu, D Bayik, E Goguet, D Tross, LP Blanco, MJ Kaplan, ... The Journal of Immunology 200 (1_Supplement), 49.8-49.8, 2018 | | 2018 |
| Effects of TLR 7 and 8 agonists on human monocyte activation and differentiation N Kayraklioglu, DM Klinman The Journal of Immunology 200 (1_Supplement), 109.8-109.8, 2018 | | 2018 |
| Pro-inflammatory properties of orally delivered calcium-encapsulated CpG Oligodeoxynucleotides N Kayraklioglu, KH Parker, J Scheiermann, DM Klinman The Journal of Immunology 198 (1_Supplement), 79.6-79.6, 2017 | | 2017 |
